Cimetadine (Tagamet)

Category:

  • Gastrointestinal

Description:

  • Antiulcer agent (H-2 receptor antagonist)

Indications:

  • Short term treatment of duodenal and benign gastric ulcers

  • Erosive gastroesophageal reflux disease (GERD)

  • Pathological hypersecretory conditions (Zollinger-Ellison syndrome, systemic mastocytosis, endocrine adenomas)

  • As part of multiple drug regiment to eradicate Helicobacter pylori in peptic ulcers

Drug Interactions:

  • Increased concentrations of interacting drugs with potential for toxicity: 

    • benzodiazepines

    • calcium channel blockers

    • carbamazepine

    • clozapine

    • cyclic antidepressants

    • glyburide

    • lomustine

    • melphalan

    • narcotic analgesics

    • nicotine

    • phenytoin

    • quinidine

    • tacrine

    • theophylline

    • tolbutamide

    • warfarin

  • Reduced concentrations of interacting drugs:

    • ketoconazole

    • cefuroxime

    • cefpodoxime

Precautions:

  • Pregnancy category B; excreted in breast milk

  • Smoking decreases effectiveness of cimetadine

  • Organic brain syndrome, hepatic disease, renal disease, elderly

Adverse Reactions (Side Effects):

  • Central Nervous System: anxiety, confusion, depression, dizziness, headache, psychosis, seizures, tremors, weakness

  • Cardiovascular: bradycardia, tachycardia

  • Gastrointestinal: abdominal cramps, diarrhea, jaundice, paralytic ileus

  • Genitourinary: Galactorrhea, gynecomastia, impotence

  • Hematological: Agranulocytosis, aplastic anemia, neutropenia, thrombocytopenia

  • Skin: Alopecia, exfoliative dermatitis, flushing rash, sweating, urticaria

 

Dosage:

Administered orally, intravenously, or intramuscularly

  • Treatment

    • PO 300mg four times daily with meals for 8 weeks or 400mg twice daily or 800mg at bedtime. After 8 weeks, give 300-400mg at bedtime only

    • IV bolus 300mg/20ml 0.9% NaCl over 1-2 minutes every 6 hours

    • IV INF 300mg/50ml D5W over 15-20 minutes every 6 hours

    • Continuous IV INF 37.5mg/hr (900mg/day)

    • IM 300mg every 6 hours not to exceed 2400mg daily.

  • Prophylaxis of duodenal ulcer: 

    • 400mg at bedtime

  • GERD: 

    • PO 800mg twice daily or 400mg four times daily for 12 weeks

 

 

 

 

Home  ·  Military Medicine  ·  Sick Call  ·  Basic Exams  ·  Medical Procedures  ·  Lab and X-ray  ·  The Pharmacy  ·  The Library  ·  Equipment  ·  Patient Transport  ·  Medical Force Protection  ·  Operational Safety  ·  Operational Settings  ·  Special Operations  ·  Humanitarian Missions  ·  Instructions/Orders  ·  Other Agencies  ·  Video Gallery  ·  Forms  ·  Web Links  ·  Acknowledgements  ·  Help  ·  Feedback

Approved for public release; Distribution is unlimited.

The information contained here is an abbreviated summary. For more detailed and complete information, consult the manufacturer's product information sheets or standard textbooks.

Source: Operational Medicine 2001, Health Care in Military Settings, NAVMED P-5139, May 1, 2001, Bureau of Medicine and Surgery, Department of the Navy, 2300 E Street NW, Washington, D.C., 20372-5300.

Bureau of Medicine and Surgery
Department of the Navy
2300 E Street NW
Washington, D.C
20372-5300

Operational Medicine
 Health Care in Military Settings
CAPT Michael John Hughey, MC, USNR
NAVMED P-5139
  January 1, 2001

United States Special Operations Command
7701 Tampa Point Blvd.
MacDill AFB, Florida
33621-5323

*This web version is provided by The Brookside Associates, LLC.  It contains original contents from the official US Navy NAVMED P-5139, but has been reformatted for web access and includes advertising and links that were not present in the original version. The medical information presented was reviewed and felt to be accurate in 2001. Medical knowledge and practice methods may have changed since that time. Some links may no longer be active. This web version has not been approved by the Department of the Navy or the Department of Defense. The presence of any advertising on these pages does not constitute an endorsement of that product or service by either the US Department of Defense or the Brookside Associates. The Brookside Associates is a private organization, not affiliated with the United States Department of Defense.

© 2015, Brookside Associates, LLC. All rights reserved

Other Brookside Products

 

 

Advertise on this site